PharmaBlock sets deadline for convertible bond redemption

PharmaBlock Sciences (Nanjing) has announced the upcoming redemption of its convertible bonds, with the last trading day set for September 12, 2025. After this date, the bonds will cease trading. The final day for bondholders to convert their bonds into shares is September 17, 2025. Unconverted bonds will be compulsorily redeemed at a price of CNY 100.62 per bond, which includes the par value and accrued interest at an annual rate of 1.5%.

The company decided to exercise its conditional redemption right after the stock price met the trigger condition, where the closing price of PharmaBlock's A-shares was at least 130% of the current conversion price for 15 trading days between July 25, 2025, and August 14, 2025. The current conversion price of the convertible bonds is CNY 33.61 per share. Investors are reminded that they must have a valid ChiNext trading account to convert their bonds into shares.

Bondholders who do not convert their bonds by September 17, 2025, risk potential investment losses as the redemption price of CNY 100.62 per bond may differ significantly from secondary market prices. The redemption funds are expected to be deposited into investors' accounts by September 25, 2025.